AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines.

AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines.

Phyton Biotech partners with PellePharm.

Agenus’ R&D Project Funded by Bill & Melinda Gates Foundation Employs PCF® Technology for Potent Vaccine Ingredient

Phyton Biotech is pleased to announce the promotion of Bryan Radu to General Manager. 

DFB Pharmaceuticals, a Fort Worth, Texas-based private investment group with an entrepreneurial drive for developing new products and businesses in healthcare, announced the promotion of Colin Marr to President of Phyton Ltd.

Phyton Biotech Wins Grant to Develop New Approaches to Manufacturing Artemisinin Bill & Melinda Gates Foundation Invests in R&D Pilot for Anti-Malarial Active Pharmaceutical Ingredients AHRENSBURG, Germany, November 29, 2017 – Phyton Biotech today announced that it has received a $400,000 grant from the Bill & [...]

Phyton Biotech showcased plant cell fermentation at CPhI Worldwide NOVEMBER 9, 2017 This October, Phyton Biotech attended CPhI Worldwide to exhibit its capabilities and the wide range of applications for the company’s proprietary Plant Cell Fermentation Technology (PCF®). CPhI Worldwide is the largest pharmaceutical industry trade [...]

Phyton Biotech Achieves Manufacturing Milestone with Thapsigargin, the Active Agent in Mipsagargin AHRENSBURG, Germany--(BUSINESS WIRE)--Phyton Biotech today announced that it has achieved a major milestone in connection with the manufacture of thapsigargin, an inhibitor derived from the Thapsia plant that is the active agent for the investigational [...]

Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO) Production of Thapsigargins by Thapsia Cell Suspension Culture" Filed by Phyton Biotech SAN ANTONIO, TX--(Marketwired - Jul 13, 2015) - GenSpera, Inc. (OTCQB: GNSZ) today announced that its strategic partner Phyton [...]